Literature DB >> 14638405

Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex.

Darius Moradpour1, Rainer Gosert, Denise Egger, François Penin, Hubert E Blum, Kurt Bienz.   

Abstract

Hepatitis C virus (HCV) replicates its genome in a membrane-associated complex composed of viral proteins, replicating RNA, and altered cellular membranes. Determinants for membrane association of the HCV nonstructural proteins involved in genome replication have been defined. In addition, a specific membrane alteration, designated membranous web, was recently identified as the site of viral RNA synthesis and, therefore, represents the HCV replication complex. These findings add to our current understanding of the HCV life cycle and may ultimately allow to design novel antiviral strategies against hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638405     DOI: 10.1016/j.antiviral.2003.08.017

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  62 in total

1.  Evidence that insertion of Tomato ringspot nepovirus NTB-VPg protein in endoplasmic reticulum membranes is directed by two domains: a C-terminal transmembrane helix and an N-terminal amphipathic helix.

Authors:  Shuo Cheng Zhang; Guangzhi Zhang; Lanying Yang; Joan Chisholm; Hélène Sanfaçon
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Inhibition effect of Chinese herbal medicine on transcription of hepatitis C virus structural gene in vitro.

Authors:  Jun Dou; Qian Chen; Jing Wang
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

3.  "Self" and "nonself" manipulation of interferon defense during persistent infection: bovine viral diarrhea virus resists alpha/beta interferon without blocking antiviral activity against unrelated viruses replicating in its host cells.

Authors:  Matthias Schweizer; Philippe Mätzener; Gabriela Pfaffen; Hanspeter Stalder; Ernst Peterhans
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Encoded library technology screening of hepatitis C virus NS4B yields a small-molecule compound series with in vitro replicon activity.

Authors:  Christopher Arico-Muendel; Zhengrong Zhu; Hamilton Dickson; Derek Parks; Jesse Keicher; Jianghe Deng; Leah Aquilani; Frank Coppo; Todd Graybill; Kenneth Lind; Andrew Peat; Michael Thomson
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

5.  Hepatitis C virus promotes virion secretion through cleavage of the Rab7 adaptor protein RILP.

Authors:  Ann L Wozniak; Abby Long; Kellyann N Jones-Jamtgaard; Steven A Weinman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

6.  Sigma-1 receptor regulates early steps of viral RNA replication at the onset of hepatitis C virus infection.

Authors:  Martina Friesland; Lidia Mingorance; Josan Chung; Francis V Chisari; Pablo Gastaminza
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

7.  Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol.

Authors:  Eve-Isabelle Pécheur; Dimitri Lavillette; Fanny Alcaras; Jennifer Molle; Yury S Boriskin; Michael Roberts; François-Loïc Cosset; Stephen J Polyak
Journal:  Biochemistry       Date:  2007-04-25       Impact factor: 3.162

8.  Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion.

Authors:  Pablo Gastaminza; Guofeng Cheng; Stefan Wieland; Jin Zhong; Wei Liao; Francis V Chisari
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

9.  Hepatitis C virus NS4B carboxy terminal domain is a membrane binding domain.

Authors:  Jolanda M P Liefhebber; Bernd W Brandt; Rene Broer; Willy J M Spaan; Hans C van Leeuwen
Journal:  Virol J       Date:  2009-05-25       Impact factor: 4.099

Review 10.  Hepatitis C Virus entry: the early steps in the viral replication cycle.

Authors:  Ali Sabahi
Journal:  Virol J       Date:  2009-07-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.